Intervention

Recombinant human hyaluronidase PH20

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions2

Lead sponsors shown1

Clinical trials

2 shown

Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human HyaluronidaseNCT01526733 · 2011-12-01

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes MellitusNCT01194258 · 2010-08-01

Common conditions

Diabetes Mellitus, Type II1 Type 1 Diabetes Mellitus1

Leading sponsors

Halozyme Therapeutics2

Trial status mix

COMPLETED2

Phase mix

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.